Stay updated on Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial

Sign up to get notified when there's something new on the Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Major change: page now includes a funding/status notice and a new v3.2.0 revision, replacing v3.0.2.
    Difference
    13%
    Check dated 2025-10-04T08:04:47.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; Back to Top element removed.
    Difference
    0.8%
    Check dated 2025-09-13T01:45:48.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.8%
    Check dated 2025-09-05T19:57:06.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location details, while removing specific state, country, and city information. This indicates a shift in how location information is presented.
    Difference
    8%
    Check dated 2025-08-29T18:40:04.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-08-15T11:44:15.000Z thumbnail image
  9. Check
    80 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-08-08T09:14:18.000Z thumbnail image

Stay in the know with updates to Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial page.